Is there a connection between methylphenidate and cancer in youth?
Zito
Julie Magno
JM
University of Maryland, Pharmaceutical Health, 220 Arch St., Baltimore, Maryland, USA. jzito@rx.umaryland.edu
Safer
Daniel J
DJ
D000293:Adolescent; D002140:California / Q000453:epidemiology; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D016208:Databases, Factual / Q000706:statistics & numerical data; D017723:Drug Utilization Review / Q000379:methods / Q000706:statistics & numerical data*; D006801:Humans; D015994:Incidence; D008774:Methylphenidate / Q000009:adverse effects* / Q000627:therapeutic use; D009369:Neoplasms / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology; D018570:Risk Assessment / Q000379:methods
D000697:Central Nervous System Stimulants; D008774:Methylphenidate